Genomics and Proteomics Reagents, Research Kits and Analytical Instruments

Genomics and Proteomics Reagents, Research Kits and Analytical Instruments

Global Genomics and Proteomics Reagents, Research Kits and Analytical Instruments Market to Reach US$156.5 Billion by 2030

The global market for Genomics and Proteomics Reagents, Research Kits and Analytical Instruments estimated at US$79.0 Billion in the year 2023, is expected to reach US$156.5 Billion by 2030, growing at a CAGR of 10.3% over the analysis period 2023-2030. Biochips & Microarrays, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$43.1 Billion by the end of the analysis period. Growth in the Sample Preparation Kits segment is estimated at 11.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$21.1 Billion While China is Forecast to Grow at 13.7% CAGR

The Genomics and Proteomics Reagents, Research Kits and Analytical Instruments market in the U.S. is estimated at US$21.1 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$34.6 Billion by the year 2030 trailing a CAGR of 13.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.7% and 7.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.9% CAGR.

Global Genomics and Proteomics Reagents, Research Kits, and Analytical Instruments Market - Key Trends & Drivers Summarized

How Are Technological Advances Shaping Genomics and Proteomics?

The genomics and proteomics market has witnessed groundbreaking advancements in technology, with next-generation sequencing (NGS), CRISPR, and mass spectrometry transforming research capabilities. These technologies enable rapid, high-throughput analysis, allowing scientists to decode genetic and protein structures faster and with greater accuracy. Advancements in automation have also led to the development of highly sophisticated analytical instruments, minimizing human error and increasing reproducibility. Such technological progress is making genomics and proteomics research more accessible, supporting a variety of applications including personalized medicine, biomarker discovery, and drug development.

Why Is Personalized Medicine Increasing Demand for Research Kits?

The rise of personalized medicine is driving demand for genomics and proteomics research kits, as these tools enable researchers to tailor treatments based on individual genetic and proteomic profiles. Kits that allow for the analysis of genetic variations and protein expression are crucial for identifying specific biomarkers associated with diseases. The growing focus on personalized treatment strategies in oncology, neurology, and cardiology has boosted the use of research kits and reagents, which are essential for conducting accurate and targeted studies. This trend supports healthcare`s shift toward customized treatment, aligning with patient-specific medical needs.

How Are Academic and Pharmaceutical Investments Fueling Market Growth?

The genomics and proteomics field is receiving significant investments from both academic institutions and pharmaceutical companies eager to advance drug discovery and precision medicine. Government funding for academic research, particularly in areas like cancer genomics and infectious disease research, is supporting the development of new reagents and analytical instruments. Pharmaceutical companies are investing in proteomics to discover new drug targets and biomarkers, leading to increased demand for advanced research tools. These investments have positioned the genomics and proteomics market for growth as research accelerates and applications expand in healthcare.

What Drives the Growth of the Genomics and Proteomics Market?

The growth in the genomics and proteomics reagents, research kits, and analytical instruments market is driven by technological advancements, the rise of personalized medicine, and increased investments in research. Innovations like NGS and CRISPR are enabling high-throughput and precise genetic analysis, which is essential for applications in drug discovery and biomarker research. Personalized medicine is also fueling demand for research tools, as patient-specific treatments require in-depth genetic and proteomic analysis. Academic and pharmaceutical investments are further bolstering market expansion, making genomics and proteomics essential components in advancing modern medicine.

Select Competitors (Total 11 Featured) -

• Advanced Instruments
• Agilent Technologies, Inc.
• AMS Biotechnology (Europe) Ltd. (amsbio)
• BD Biosciences
• Bioevopeak Co., Ltd.
• Biognosys
• Bio-Rad Laboratories, Inc.
• Biosynth AG
• Breakthrough Genomics
• Bruker Corporation

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.